TP53 and cancer: More than 50% of all human cancers and 10–50% of HCC (depending on the etiology/risk factors including HBV, HCV and aflatoxin exposure) harbor TP53 mutations, highlighting the importance of P53 in (hepato-)carcinogenesis [4,6].